genXone S.A. (WSE:GX1)
Poland
· Delayed Price · Currency is PLN 6.20
+0.20 (3.33%)
At close: Jun 27, 2025, 4:50 PM CET
genXone Market Cap
genXone has a market cap or net worth of 20.49 million as of June 27, 2025. Its market cap has increased by 1.23% in one year.
Market Cap
20.49M
Enterprise Value
15.61M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.20
Market Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 20.49M, a decrease of -85.54%. That is a compound annual growth rate of -33.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 20.36M | -0.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | 69.13M | -51.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.08B |
| Synektik Spólka Akcyjna | 1.83B |
| Voxel | 1.62B |
| Celon Pharma | 1.17B |
| Ryvu Therapeutics | 729.44M |
| Centrum Medyczne ENEL-MED | 551.47M |
| Selvita | 541.49M |
| Bioceltix | 516.08M |